# Patrick Chung

> Patrick Chung is a Series A investor at Xfund (Palo Alto) backing Software and Health Care. See 49 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Xfund](https://shizune.co/investors/profile/xfund)
- Location: Palo Alto, United States
- Total investments: 49
- Last investment: Nov 2021
- Lead investor: 16%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/patrick-s-chung/0/59b/890/
- X (Twitter): http://twitter.com/patrickchung
- Website: https://www.patrickchung.org/
- Facebook: https://www.facebook.com/pschung

Patrick Chung is a Series A investor at Xfund in Palo Alto focused on Software and Health Care. Patrick Chung is the Managing General Partner of Xfund. He attended Harvard University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 8 | 16% |
| Health Care | 5 | 10% |
| Mobile | 4 | 8% |
| Analytics | 4 | 8% |
| E-Commerce | 4 | 8% |

64 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 16 | 33% |
| Seed | 13 | 27% |
| Series B | 8 | 16% |
| Series C | 3 | 6% |
| Series D | 3 | 6% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 24 | 49% |
| Canada | 1 | 2% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Uvaro | Uvaro's career success platform includes training, paid experience, advancement, and ongoing coaching to ensure long-term career success. Their training program includes on-demand and live classes. Their virtual internships let companies hire talent based on performance. Their coaching and mentorship network drive ongoing career growth. | $12M | Series A | Nov 03, 2021 |  |
| Guideline | Guideline an all-inclusive 401(k) technology designed for growing businesses. Guideline handles all plan administration, including set-up, participant enrollment and education, recordkeeping, investment management, compliance, and reporting. Guideline is the first full-service 401(k) with straightforward pricing of one flat fee per participant, incontrast to the asset-based fee model predominant in the industry. | $200M | Series E | Jun 16, 2021 |  |
| Curebase | Curebase is the modern eClinical platform built for flexibility, usability, and full-study oversight. We empower sponsors, CROs, and sites to launch studies faster, deliver better participant experiences, and seamlessly capture data with next-gen, AI-powered ePRO, eConsent, engagement tools, and integrated EDC. | $15M | Series A | May 25, 2021 |  |
| kea | Kea empowers restaurants to operate more intelligently and own their relationship with customers. Its product, Kea Voice, takes orders over the phone at a high level of efficiency and consistency so that restaurants can focus on making delicious food.Launched in 2018, Kea is one of the fastest-growing companies on a course to change the wayrestaurants operate. The company is headquartered in Mountain View, California. | $10M | Series A | Nov 20, 2020 |  |
| Uvaro | Uvaro's career success platform includes training, paid experience, advancement, and ongoing coaching to ensure long-term career success. Their training program includes on-demand and live classes. Their virtual internships let companies hire talent based on performance. Their coaching and mentorship network drive ongoing career growth. | $1.6M | Seed | Sep 01, 2020 |  |
| Guideline | Guideline an all-inclusive 401(k) technology designed for growing businesses. Guideline handles all plan administration, including set-up, participant enrollment and education, recordkeeping, investment management, compliance, and reporting. Guideline is the first full-service 401(k) with straightforward pricing of one flat fee per participant, incontrast to the asset-based fee model predominant in the industry. | $80M | Series D | Jul 29, 2020 |  |
| kea | Kea empowers restaurants to operate more intelligently and own their relationship with customers. Its product, Kea Voice, takes orders over the phone at a high level of efficiency and consistency so that restaurants can focus on making delicious food.Launched in 2018, Kea is one of the fastest-growing companies on a course to change the wayrestaurants operate. The company is headquartered in Mountain View, California. | $6.7M | Seed | May 15, 2019 |  |
| Landit | Landit is a technology platform that increases the success and engagement of women and diverse groups in the workplace. The market leader in personalized career pathing, Landit creates a turnkey “one size fits one” solution that enables enterprises to attract, develop, and retain high-potential diverse talent. Landit provides each member with apersonalized playbook that empowers them with the tools, resources, know-how, and human connections they need to advance and navigate their career path. Key features include building a personal brand, executive coaching, creating a personal board of advisors, curated skill development and mapping to career opportunities. | $13M | Series A | Feb 26, 2019 |  |
| Curebase | Curebase is the modern eClinical platform built for flexibility, usability, and full-study oversight. We empower sponsors, CROs, and sites to launch studies faster, deliver better participant experiences, and seamlessly capture data with next-gen, AI-powered ePRO, eConsent, engagement tools, and integrated EDC. | $2.5M | Seed | Oct 19, 2018 |  |
| Nebula Genomics | Nebula Genomics is a human genome sequencing and health big data company on a mission to usher in the era of genomic sequencing by building a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for itsuse, the Nebula marketplace will aggregate a critical mass of rich genetic information that researchers can analyze in order to accelerate drug development, streamline clinical trials, and usher in the era of truly personalized medicine. The company was founded by Harvard genomics pioneer George Church, along with Harvard researchers Dennis Grishin and Kamal Obbad. Founded in 2017, Nebula Genomics has offices in San Francisco, CA and Boston, MA and is backed by investors including Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, GreatPoint Ventures, Hemi Ventures and Mirae Asset. | $4.3M | Series A | Oct 10, 2018 |  |

10 of 49 investments shown.

## Co-investors
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 6 deals together
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund, 6 deals together
- [Experiment Fund](https://shizune.co/investors/profile/experiment-fund) — VC Fund, 5 deals together
- [Lerer Hippeau](https://shizune.co/investors/profile/lerer-ventures) — VC Fund, 5 deals together
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund, 4 deals together
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 3 deals together

## About Xfund

VC Fund · Palo Alto, United States

Xfund is the early-stage venture firm designed to back lateral thinkers. Partnering with Harvard University and others of the world’s preeminent universities, Xfund looks beyond the stereotypical technical pedigrees to seek out extraordinary people who are being systemically ignored by traditional venture capital: technically-gifted liberal artsentrepreneurs. We believe it’s our responsibility to help these unconventional, high potential founders align their ambition and passion with opportunity we help them create, to build the sort of ground-breaking companies that can create a better tomorrow. Xfund has offices in Palo Alto, California, and in Cambridge, Massachusetts. For more about Xfund, please visit http://www.xfund.com.

3 contacts available at Xfund.

| Name | Title | Profile |
| --- | --- | --- |
| Peter Morris | Investment Advisory Board | https://shizune.co/investors/profile/peter-morris-ne |
| Brandon Farwell | General Partner | https://shizune.co/investors/profile/brandon-farwell |
| Patrick Chung | Managing General Partner | https://shizune.co/investors/profile/patrick-chung |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Patrick Chung invest in?

Patrick Chung invests primarily in Software, Health Care and Mobile startups, most often at Series A and Seed stage. Most of the 49 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Patrick Chung last invest?

The most recent investment recorded for Patrick Chung closed in Nov 2021. Shizune tracks 49 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co